17060-Skin Cancer-NA-580

Skin Cancer

A Phase II, Open-Labeled, Single Arm Study to Evaluate the Safety and Tolerability of Pembrolizumab in Participants with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (629)

  • Details

ClinicalTrials.gov ID: NCT03284424
Diagnosis Type: NA
USOR Number: 17060

  • Address

2070 W Rudasill Rd, Suite 130
Tucson, AZ 85704
P: (520) 797-4468

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.